Jeremy Green, 10% Owner at Neoleukin Therapeutics, Inc. (NLTX), sold 39,036 shares at $11.06 ($437K) on 2020-04-01, disclosed to the SEC on 2020-04-06.
Open-market sale of $437k NLTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.06 | 9,634 | $107K | 24.4% |
| 2 | $11.06 | 9,634 | $107K | 24.4% |
| 3 | $11.87 | 200 | $2K | 0.5% |
| 4 | $11.30 | 9,734 | $110K | 25.2% |
| 5 | $11.30 | 9,734 | $110K | 25.2% |
| 6 | $11.82 | 100 |
| $1K |
| 0.3% |
| Total | $11.19 avg | 39,036 | $437K | 100% |
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |